Treatment | Page 123 of 465

Vitamin A :: A potential role for retinoic acid in autoimmune and inflammatory diseases

An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced today by researchers at the La Jolla Institute for Allergy & Immunology. The studies, conducted in laboratory mice, demonstrated the role of retinoic acid, a substance derived when vitamin A is broken down in the body, in regulating inflammation.

Ovarian Cancer :: Hormone therapy offers new hope for ovarian cancer patients

Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

Cancer :: NCI launches a pilot of its Community Cancer Centers program to bring quality cancer care to all

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), today launched the three-year pilot phase of a new program that will help bring state-of-the-art cancer care to patients in community hospitals across the United States.

Autism :: Study to search for more answers on autism subject

A research study that may provide hope of finding an effective, alternative intervention for children with autism who do not respond to Intensive Behavioural Intervention (IBI), is being conducted under the leadership of McMaster University.

Stroke :: Risk of stroke doubles if diagnosed with Type 2 diabetes

Individuals diagnosed with Type 2 diabetes are at double the risk of having a stroke compared to those without diabetes, according to new research from the University of Alberta. It was found that the risk of a stroke is considered high within the first five years of treatment for Type 2 diabetes, and more than doubles the rate of occurrence.

Lupus :: Treatment with Belimumab showed improvement in symptoms in 46 percent of lupus patients at 52 weeks

Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus disease activity in 46 percent of patients at week 52, according to a novel combined responder index in results presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

Rheumatoid Arthritis :: Gender disparity in anti-TNF treatment for rheumatoid arthritis

Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs — very effective but expensive modern medications against this disease — at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.

Osteoarthritis :: Aggressive nature of hand osteoarthritis

In just two years, patients with hand osteoarthritis experienced a significant increase in pain and functional limitations, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. Statistically significant radiological progression was also detected in 20 percent of subjects.

Lymphoma :: Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids

Two years or more of oral steroid treatment decreases the risk of rheumatoid arthritis related lymphoma, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain. Furthermore, these effects were found regardless of when in the course of the disease the steroids were first administered. However, these beneficial effects were not observed if the steroids were taken for less than a two-year period.

Rheumatoid Arthritis :: One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex

Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.